Endoscopy On Air brings you a message from Boston Scientific Endoscopy: One portfolio. More possibilities for biliary care. Explore how the WallFlex™ portfolio, including the WallFlex™ Biliary PLUS RX Stent System, supports treatment approaches for diverse patient needs and anatomies. Join us on June 5th, 8:00 AM – 10:00 PM CEST to learn more about the WallFlex™ portfolio (bostonscientific.com/en-EU/p…) and discover the latest advances in therapeutic endoscopy. #EndoscopyOnAir #BostonScientific #AdvancingScience #Endoscopy 👉 Register now  endoscopyonair.com/event/end…

Congratulations @karenluMD @MoffittNews on an inspiring #SGOAM2026 Presidential address and the #impact you have made to our field, patients, physicians, and #teams. @gynoncjnls #cancergenetics #advancingscience #empoweringteams #embracingchange

Round 2 of our social media ambassadors! At #SGOAM2026 in Puerto Rico. We encourage you to follow them and check here regularly for updates throughout the conference on the latest science! #Advancingscience #Empoweringteams #Embracingchange @tsialater @meddles28 @TeresaBoitano @nicoleflemingmd

SGO 2026 in San Juan, here we come! We are excited to be partnering with several social media ambassadors. We encourage you to follow them and check here regularly for updates throughout the conference on the latest science! #Advancingscience #Empoweringteams #Embracingchange @ShannonWestin @MeganLeigh127 @RiosDoriaMD @David_Cohn_MD @SusanModesitt

#TBT: A historical moment when Minister Ramokgopa along with Deputy Minister Samantha Graham-Maré unveiled the SAFARI-1 60th anniversary plaque. @iaeaorg @DOEE_ZA #SAFARI-1Turns60 #SAFARI-1Anniversary #NuclearScience #NuclearInnovation #AdvancingScience #ProudlySouthAfrican

Thank you to Ochre Bio for welcoming our team during our recent staff retreat and for the engaging tour and presentation of their innovative work. Seeing cutting-edge liver science in action and connecting with others who share our commitment to advancing liver health was truly energizing. We’re grateful for their hospitality and for the opportunity to learn from their team. #ALF50 #LiverHealth #InnovationInMedicine #ResearchMatters #AdvancingScience

Empowering skills, advancing science ! CSIR-Indian Institute of Integrative Medicine (CSIR-IIIM) Jammu is hosting a hands-on training on “Formulation & Extraction of Medicinal Plants in cGMP Pilot Plant” from 17th to 20th February 2026 under its Integrated Skill Initiatives. Focused on job-oriented skills, practical exposure, and capacity building, this programme supports young professionals and researchers in translating herbal science into real-world applications. #EmpoweringSkills #AdvancingScience #CSIRIIIM #MedicinalPlants #HandsOnTraining #cGMP #HerbalScience #CapacityBuilding #JobOrientedSkills #IntegratedSkillInitiatives

American Liver Foundation would to extend its sincere appreciation to the individuals whose expertise and commitment made this year’s 34th Annual Arias Symposium possible, including event co-hosts Dr. Bhatia, Dr. Goessling, and Dr. Fleming, speakers, event co-chairs, session chairs, poster judges, event sponsors, @MIT, ALF staff, and of course, the incredible Dr. Irwin M Arias, whose legacy is recognized globally for driving progress in liver disease research and the development of new treatments and cures. Learn more about the historic event: alf.social/arias25pr #AriasSymposium #LiverResearch #MedicalInnovation #AdvancingScience #livertwitter

We are proud to join the ASFI 5–10 Program 2026, a continental initiative building sustainable research capacity across Africa. Ten academic staff have received full ASFI scholarships! #KaratinaUniversity #EmpoweringScholars #AdvancingScience #InspiringInnovationandLeadership

🧡 May is Multiple Sclerosis Awareness Month. At Quantum BioPharma, we're dedicated to advancing science and restoring hope for those affected by demyelination in MS. Together, we're committed to pioneering research that aims to protect nerves, preserve abilities, and improve quality of life. Let's spread awareness, ignite hope, and accelerate progress against MS—today and every day. #MSAwarenessMonth #QuantumBioPharma #QNTM #MultipleSclerosis #AdvancingScience #Neuroscience #HopeThroughInnovation $QNTM #QNTM

Demyelination is a challenge faced by those living with Multiple Sclerosis, a condition that strips nerves of their protective coating, impacting mobility and quality of life. At Quantum BioPharma, we're dedicated to turning the tide on MS with our patented compound, Lucid-MS. We believe that Lucid-MS holds the promise of promoting remyelination—helping to restore this crucial protective layer. Driven by a mission to change lives through scientific innovation, our team is working tirelessly to advance our research. Every day, we're moving closer to a future where MS patients can experience significant improvements in their symptoms and overall well-being. #AdvancingScience #ChangingLives #MSAwareness #Biotech #Multiplesclerosis #Neurodegenerative #Medicine #Remyelination #LucidMS #QNTM $QNTM

Necsa Group CEO Mr Loyiso Tyabashe and Nuclear DDG at @DMRE_ZA following the unveiling of the plaque by @MOEE_ZA Kgosientsho Ramokgopa #SAFARI-1Turns60 #SAFARI-1Anniversary #NuclearScience #NuclearInnovation #AdvancingScience #ProudlySouthAfrican #CleanEnergy

Celebrating the grand opening of the Biorepository at the Hussman Institute, a milestone for groundbreaking research and innovation! #AdvancingScience #HussmanInstitute

Feeling incredibly grateful to have received this thoughtful bracelet from @SclcSMASHERS —a group that does so much for patients with #SCLC and their families. 2024 was a year of tremendous progress for #SmallCellLungCancer: ✅ Advances in understanding its biology ✅ New clinical developments bringing hope …but there’s still so much more work to be done. Fondly remember the inspiring Facebook Live with @drshieldsmd (@SclcSMASHERS), Dr. Upal Basu Roy of @LUNGevity. It's conversations like these that remind us why we keep pushing forward. Here’s to continued teamwork, innovation, and impact in 2025! 💪 @IcahnMountSinai @TischCancer @oncodaily @acmoorephd @OncLive @lcsmchat #LCSM #LungCancer #SCLC #Hope #AdvancingScience #PatientAdvocacy #advocacymatters

As we approach the end of 2024, we would like to thank everyone who has supported us throughout this remarkable year. Your unwavering support has been instrumental in our success, and we can't wait to support the discoveries in 2025. #AdvancingScience #HappyHolidays

Discover how Quantum BioPharma is taking a groundbreaking approach to Multiple Sclerosis (MS) research. Our leading drug candidate, Lucid-MS, aims to promote remyelination of damaged neurons in the brain and spinal cord, offering hope to MS patients worldwide. Quantum BioPharma’s mission: "Advancing Science, Saving Lives" Latest updates on MS research 🌐Learn More: Visit Quantum BioPharma's Website quantumbiopharma.com 📢 Stay Connected: info@quantumbiopharma.com #QuantumBioPharma #LucidMS #MultipleSclerosis #MSResearch #NeuroScience #MedicalBreakthrough #AdvancingScience #SavingLives #BrainHealth #MSAwareness #HopeForMS 👍 Like, Share & Subscribe for More Scientific Insights!

Watch our video featuring Jason Sawyer, where he shares the groundbreaking approach of Lucid-MS in addressing Multiple Sclerosis. Unlike most MS therapies that focus solely on immunomodulation, Lucid-MS is designed to meet the critical need for remyelinating treatments. By targeting the neurodegenerative aspects of MS, Lucid-MS aims to support the regeneration of the myelin sheath around neurons in the brain and spinal cord. This restoration of the protective layer could potentially help improve nerve function and slow disease progression. While ongoing trials are needed to scientifically validate our approach, we are encouraged by the potential of Lucid-MS to make a real difference in the lives of MS patients as we move forward with this important work #MultipleSclerosis #LucidMS #QuantumBioPharma #BiotechInnovation #Remyelination #NeurodegenerativeDisease #MSResearch #Nasdaq #AdvancingScience #BiotechInvestments #NeuroRestoration #ClinicalTrials #MSAwareness #NextGenBiotech #NeurologyResearch #DrugDevelopment #Multiplesclerosis #Brainhealth

Genetic Cancer Predisposition in children and adolescents ⁦@CHOPCancerCntr⁩ ⁦@CHOPRadiology⁩ ⁦@ChildrensPhila⁩ Dr Christian Kratz #LiFraumeni spectrum #polygenicscores #registries #advancingscience ⁦@draash⁩ ⁦@KShekdarMD⁩ ⁦@ErinSchwartzMD⁩

Congrats on an impactful and well done paper @ruiwangphd #cancersucks #advancingscience

Ever wondered what goes into creating new treatments for neurodegenerative diseases? Meet Dr. Lakshmi P. Kotra, one of our lead researchers pushing boundaries at Quantum BioPharma with the discovery of our lead compound LUCID-MS. Recipient of the Julia Levy Award (2021) Dr. Lakshmi Kotra, Senior Scientist at Krembil Brain Institute, University Health Network (UHN), and Professor of Medicinal Chemistry at the University of Toronto, joined Quantum BioPharma as CEO of its wholly-owned subsidiary, Lucid, upon completion of its acquisition of Lucid Psycheceuticals in September 2021. Dr. Kotra received his Ph.D. in Pharmacy/Medicinal Chemistry from the University of Georgia and completed postdoctoral training at Wayne State University. He has authored/co-authored over 130 publications and delivered over 140 scientific talks internationally. Dr. Kotra is the recipient of several awards, including the Julia Levy Award from the Society of Chemical Industry (SCI) Canada in recognition of his substantial contribution to the successful commercialization of innovation in Canada in the field of biomedical science and engineering. An academic entrepreneur, Dr. Kotra has contributed to a number of important drug discovery and development projects, including anti-HIV drugs, antibacterials, insulin, antimalarials, medical cannabis-based therapeutics, and drugs targeting multiple sclerosis. utoronto.ca/celebrates/laksh… #AdvancingScience #MeetTheTeam #InnovationInAction #Biotech #MS #Multiplesclerosis #Neurodegenerative #Brainhealth